Department of Cancer Biology, The Kansas University Medical Center, 3901 Rainbow Blvd., Kansas City, KS, 66160, USA.
The University of Kansas Cancer Center, 3901 Rainbow Blvd, Kansas City, KS, 66160, USA.
Cancer Metastasis Rev. 2020 Sep;39(3):755-768. doi: 10.1007/s10555-020-09871-0.
Despite high mortality rates, molecular understanding of metastasis remains limited. It can be regulated by both pro- and anti-metastasis genes. The metastasis suppressor, breast cancer metastasis suppressor 1 (BRMS1), has been positively correlated with patient outcomes, but molecular functions are still being characterized. BRMS1 has been implicated in focal adhesion kinase (FAK), epidermal growth factor receptor (EGFR), and NF-κB signaling pathways. We review evidence that BRMS1 regulates these vast signaling pathways through chromatin remodeling as a member of mSin3 histone deacetylase complexes.
尽管死亡率很高,但对转移的分子理解仍然有限。它可以通过促进转移和抑制转移的基因来调节。转移抑制因子,乳腺癌转移抑制因子 1(BRMS1)与患者的预后呈正相关,但分子功能仍在研究中。BRMS1 参与粘着斑激酶(FAK)、表皮生长因子受体(EGFR)和 NF-κB 信号通路。我们回顾了 BRMS1 通过作为 mSin3 组蛋白去乙酰化酶复合物的成员来调节这些广泛的信号通路的证据,这些信号通路通过染色质重塑来调节。